Start / The Long Run with Luke Timmerman / Ep135 john maraganore on developing a new class of medicines

Ep135: John Maraganore on Developing a New Class of Medicines

64 min • 8 maj 2023

John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference as a new class of medicine.

Kategorier

Förekommer på

00:00 -00:00